8-K: SenesTech Reports Record Q3 Revenue, Improved EBITDA

SenesTech, Inc. announced record third-quarter 2025 financial results, including 43% revenue growth and improved Adjusted EBITDA, driven by strong Evolve product sales and multi-channel expansion.

Summary

• Record revenues of $690,000 in Q3 2025, a 43% increase from $482,000 in Q3 2024.
• Evolve Rodent Birth Control product sales grew 77% year-over-year, now comprising 85% of total revenue.
• Gross profit margin stood at 62.8%, in line with expectations.
• Net loss improved to $1.3 million in Q3 2025, down from $1.5 million in Q3 2024, even with $111,000 in one-time legal expenses.
• Adjusted EBITDA loss improved to a record $1.2 million in Q3 2025, compared to $1.4 million in Q3 2024.
• Cash and short-term investments totaled $10.2 million as of September 30, 2025, providing a solid operating runway.
• E-commerce revenue increased 55% year-over-year, driven by double-digit growth on Amazon and accelerating growth on Walmart.com and HomeDepot.com.
• Municipal revenue grew 139% year-over-year due to expanded deployments in New York City, Chicago, and other locations.
• Retail revenue saw a 254% year-over-year increase, driven by expanded adoption by Ace Hardware and follow-on orders from Bradley Caldwell.
• Pest management professional (PMP) revenue increased 29% year-over-year and 72% sequentially, representing nearly 20% of overall Q3 2025 revenue.

Sentiment

Score: 8

Explanation: The company reported record revenue, significant year-over-year growth across all key channels, and improved profitability metrics (reduced net loss and Adjusted EBITDA loss). The strong cash balance provides a solid operating runway, and management expresses confidence in achieving profitable growth and breakeven goals. While still operating at a loss, the positive trends are substantial.

Positives

• Record revenues of $690,000, a 43% increase year-over-year.
• Evolve Rodent Birth Control product sales grew 77% year-over-year, now representing 85% of total revenue.
• Gross profit margin maintained at 62.8%.
• Net loss improved to $1.3 million from $1.5 million in the prior year quarter.
• Adjusted EBITDA loss improved to a record $1.2 million from $1.4 million in the prior year quarter.
• Strong cash and short-term investments balance of $10.2 million provides a solid operating runway.
• E-commerce revenue increased 55% year-over-year, with double-digit growth on Amazon and accelerating growth on Walmart.com and HomeDepot.com.
• Municipal revenue grew 139% year-over-year due to expanded deployments in New York City, Chicago, and other locations.
• Retail revenue surged 254% year-over-year, driven by Ace Hardware expanding coverage and follow-on orders from Bradley Caldwell.
• Pest management professional (PMP) revenue increased 29% year-over-year and 72% sequentially.
• Research and development expenses decreased to $400,000 from $451,000 year-over-year.
• Selling, general and administrative expenses decreased to $1,380,000 from $1,411,000 year-over-year.

Negatives

• The company still reported a net loss of $1.3 million for the quarter.
• Adjusted EBITDA remains a loss of $1.2 million.
• One-time legal expenses of $111,000 were incurred in Q3 2025.

Risks

• The successful commercialization of products.
• Market acceptance of products.
• Financial performance, including the ability to fund operations.
• Ability to maintain compliance with Nasdaq's continued listing requirements.
• Regulatory approval and regulation of products.
• Other factors and risks identified in the Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

Future Outlook

The company intends to pursue profitable growth, leveraging its strong balance sheet to achieve breakeven goals and realize the long-term potential of introducing a novel product category into the pest control market. They expect accelerated growth across e-commerce sites, additional municipal deployments, and future retail growth from e-commerce expansion to in-store offerings.

Management Comments

• "We are pleased to report another quarter of strong results, reflecting the growing adoption of our Evolve product line."
• "Our multi-channel distribution strategy continues to take hold, with meaningful contributions from e-commerce, municipal programs, retail partners, and pest management professionals."
• "These results are a credit to careful planning, disciplined execution, and a continued focus on efficiency, which together supported healthy margins and our strongest Adjusted EBITDA to date."
• "With a strong balance sheet, highlighted by more than $10 million in funding available at the end of September, we intend to pursue profitable growth moving forward."
• "This positions us to work toward achieving our breakeven goals and to realize the long-term potential of introducing a novel product category into the pest control market."

Industry Context

SenesTech operates in the pest control market, specifically focusing on fertility control for animal pest populations. The strong growth in Evolve products and multi-channel distribution suggests increasing acceptance of non-lethal, proactive pest management solutions, potentially driven by environmental concerns and demand for sustainable alternatives to traditional rodenticides. The expansion into municipal and retail channels indicates a broader market penetration strategy beyond specialized pest management professionals, aligning with a trend towards more accessible and diverse pest control options.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to benchmark against global industry standards. However, the company positions itself as the 'leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control products,' suggesting a unique market position rather than direct competition with traditional pest control methods.

Stakeholder Impact

• Shareholders: Positive impact due to record revenue, improved financial performance, strong cash position, and positive future outlook. Potential for increased share value if growth and profitability targets are met.
• Customers (Pest Management Professionals, Municipalities, Retailers, E-commerce Consumers): Continued availability and expansion of Evolve products, indicating reliable supply and broader access to fertility control solutions.
• Employees: Continued growth and progress towards profitability could lead to job security and potential expansion.

Next Steps

• Pursue profitable growth.
• Work toward achieving breakeven goals.
• Realize the long-term potential of introducing a novel product category into the pest control market.
• Continue expanding municipal deployments.
• Expand retail offerings from e-commerce to in-store.

Key Dates

Recommendation

The filing demonstrates significant positive momentum with record revenue growth (43% YoY), substantial improvements in net loss and Adjusted EBITDA loss, and robust expansion across all sales channels (Evolve products up 77%, e-commerce up 55%, municipal up 139%, retail up 254%). The company's strong cash position of $10.2 million provides a solid operating runway, supporting its stated goal of achieving profitable growth and breakeven. These results indicate strong market acceptance for its novel fertility control products and effective execution of its multi-channel strategy. The company is establishing itself as a leader in a unique and growing segment of the pest control market, suggesting significant upside potential for investors.

Keywords

SenesTech, SNES, Q3 2025, Financial Results, Rodent Control, Fertility Control, Evolve, ContraPest, Pest Management, EBITDA, Revenue Growth, E-commerce, Municipal Programs, Retail Adoption, EPA-registered